Research Pharmacy: How Sites Set Up, Staff, and Run an Investigational Drug Service

A research pharmacy — also called an Investigational Drug Service (IDS) — is the unit inside a hospital, health system, or academic medical center responsible for receiving, storing, preparing, dispensing, and tracking investigational drugs used in clinical trials. Most institutions that run more than a handful of drug trials eventually need one, whether that means a single trained pharmacist covering research duties part-time or a dedicated IDS with its own space, staff, and standard operating procedures.

CASRAI’s research pharmacy dictionary entry defines the concept and its regulatory basis. The companion Research Pharmacy SOP guide walks through what a written SOP document actually contains, section by section. This guide covers different ground: how a research pharmacy is actually set up and run as an operating unit — the space and equipment it needs, how it’s staffed, what its day-to-day workflow looks like from protocol activation through study closeout, and where it sits organizationally relative to the rest of a clinical trials office.

Why a Research Pharmacy Function Exists

Investigational drugs carry regulatory obligations that a hospital’s normal inpatient or outpatient pharmacy workflow isn’t built to satisfy. Under FDA regulations, the investigator is responsible for maintaining adequate accountability records showing the disposition of investigational drugs, including dates, quantities, and the subjects to whom the drug was administered (21 CFR 312.61 and 312.62). In practice, investigators delegate that accountability function to a pharmacist, and ICH E6 Good Clinical Practice similarly expects that investigational product (IP) be received, handled, stored, and dispensed under adequate, documented control — typically by a pharmacist or another appropriately qualified individual under the investigator’s supervision.

A research pharmacy exists to absorb that obligation in one place rather than leaving it to individual investigators or research coordinators without pharmacy training. It also protects the rest of the pharmacy’s clinical operations: investigational drugs often have protocol-specific dosing, blinding, and storage rules that don’t map onto a hospital’s standard formulary systems, so mixing them into ordinary pharmacy workflow creates real risk of dosing or dispensing errors.

Core Functions of a Research Pharmacy

Regardless of size, a research pharmacy typically performs the same core set of functions for every protocol it supports:

• Receipt and inventory intake — accepting investigational product shipments from the sponsor or a central/depot pharmacy, verifying quantities and condition against shipping documentation, and confirming any temperature-monitoring data (see cold chain and temperature excursion) fell within the protocol’s specified range before product is released to inventory.
• Storage — maintaining product under the conditions the protocol and manufacturer specify (refrigerated, frozen, controlled room temperature, light-protected), with continuous temperature monitoring and documented excursion response, and physically separating investigational stock from commercial formulary stock.
• Preparation and compounding — for sterile injectable or hazardous investigational products, compounding under USP <797> (sterile preparations) and, where the drug is a hazardous agent such as an investigational oncology compound, USP <800> (handling of hazardous drugs), in a facility with the appropriate engineering controls.
• Dispensing and drug accountability — dispensing to the subject or administering clinician against a specific subject and visit, and logging every unit dispensed, returned, or destroyed on a drug accountability log that a sponsor monitor will review at every monitoring visit.
• Randomization and blinding support — in blinded trials, the research pharmacist is frequently the only site staff member with access to treatment assignment, using an Interactive Response Technology (IRT/IWRS) system to obtain and dispense the correct blinded kit while maintaining the blind for the rest of the site team.
• Controlled substance handling — for investigational products that are themselves DEA-scheduled or that involve a scheduled comparator, maintaining a separate controlled substance inventory and DEA registration as applicable (see Controlled Substance Inventory and DEA Form 225).
• Return, reconciliation, and destruction — at study closeout or on sponsor instruction, reconciling all product received against all product dispensed, destroyed, or returned, and documenting final disposition for the sponsor’s records.

Staffing a Research Pharmacy

How a research pharmacy is staffed scales with trial volume:

• Low-volume sites often designate one or two pharmacists with research training to handle investigational drug duties alongside their regular dispensing role, activating a protocol-specific workflow only when a trial requiring pharmacy involvement opens.
• Mid-to-high-volume academic medical centers and cancer centers typically run a dedicated IDS with its own pharmacist(s), one or more research pharmacy technicians, and a pharmacy coordinator who manages protocol binders, sponsor correspondence, and monitor visit logistics.
• Research pharmacy technicians handle much of the routine workload under a pharmacist’s supervision — receiving and logging shipments, pulling and preparing doses against a physician or protocol order, maintaining the accountability log, and preparing documentation for monitoring visits. This is a distinct, protocol-driven skill set from general pharmacy technician work, and several institutions and professional bodies offer research-pharmacy-specific technician training.

A pharmacist assigned to research duties is typically named on the trial’s delegation of authority log and, for FDA-regulated trials, may need documented training on the specific protocol and on Good Clinical Practice generally — the same credentialing expectation applied to any other delegated study team member.

Space and Equipment

A dedicated research pharmacy space typically includes:

• Secure, access-controlled storage separate from general pharmacy stock, sized and configured for the temperature ranges the site’s protocol portfolio requires (ambient, refrigerated 2–8°C, and frozen storage, sometimes down to -80°C for biologics).
• Continuous electronic temperature monitoring with alarm and excursion-logging capability — increasingly expected by sponsors and monitors as standard practice rather than a nice-to-have (see Laboratory Environmental Monitoring).
• A compounding area meeting USP <797> engineering-control requirements if the site handles sterile investigational products, with additional USP <800> containment (e.g., a containment primary engineering control) if it handles hazardous investigational agents.
• Locked, DEA-compliant storage for any investigational or comparator product that is itself a controlled substance.
• Document storage or an electronic system for protocol binders, drug accountability logs, temperature logs, and correspondence — these are essential documents an FDA or sponsor auditor will expect to review on demand.

Workflow: From Protocol Activation to Study Closeout

1. Protocol review and activation — the research pharmacist reviews the protocol and pharmacy manual (a sponsor-provided document describing IP handling, dosing, and dispensing requirements specific to that trial) before the site can enroll subjects, and confirms the pharmacy has the storage capacity and staff training the protocol requires.
2. IP receipt — initial and subsequent shipments are received, inspected, and logged against shipping and temperature documentation.
3. Per-subject dispensing — for each dosing visit, the pharmacy prepares and dispenses (or, for blinded trials, obtains via IRT and dispenses) the correct kit or dose against the physician/protocol order, documenting lot number, expiry, and quantity on the accountability log.
4. Ongoing monitoring support — sponsor monitors periodically review accountability logs, temperature logs, and storage conditions during monitoring visits (see Site Initiation Visit Checklist), reconciling what was shipped against what was dispensed, returned, or destroyed.
5. Closeout and final reconciliation — at study end, the pharmacy performs a final accountability reconciliation and either returns unused product to the sponsor or destroys it per sponsor instruction and documented procedure, closing out the pharmacy’s portion of the trial master file.

Research Pharmacy vs. Related Functions

It’s worth distinguishing the research pharmacy from adjacent roles it’s sometimes confused with:

• Research pharmacy vs. the Clinical Trials Office (CTO): the CTO coordinates the trial as a whole — budgets, contracts, regulatory submissions, coordinator staffing — while the research pharmacy is one specialized functional unit that supports it, focused specifically on investigational product handling.
• Research pharmacy vs. comparator sourcing: when a trial requires a marketed drug as an active comparator rather than a novel investigational agent, comparator sourcing covers how that product is procured; the research pharmacy still typically stores, dispenses, and tracks it under the same accountability discipline as the investigational arm.
• Research pharmacy vs. retail/inpatient pharmacy: a hospital’s regular pharmacy dispenses FDA-approved drugs against standard formulary and billing workflows; a research pharmacy operates under protocol-specific, sponsor-defined rules that don’t follow normal formulary logic, which is precisely why the function is usually kept organizationally separate even when staffed by the same department.

Frequently Asked Questions

What is a research pharmacy?

A research pharmacy, also called an Investigational Drug Service (IDS), is the pharmacy unit responsible for receiving, storing, preparing, dispensing, and tracking investigational drugs used in clinical trials at a hospital, health system, or research institution.

What is a clinical trial pharmacy?

“Clinical trial pharmacy” and “research pharmacy” refer to the same function — a pharmacy operation dedicated to handling investigational product for clinical research rather than standard formulary dispensing.

What does a research pharmacy manual cover?

A sponsor-provided pharmacy manual is a protocol-specific document describing how investigational product for that trial must be received, stored, prepared, dosed, and dispensed, including any blinding procedures. It supplements — but doesn’t replace — the site’s own general research pharmacy SOP; see the Research Pharmacy SOP guide for how that site-level document is structured.

What does a research pharmacy technician do?

A research pharmacy technician performs the routine, protocol-driven tasks of the IDS under a pharmacist’s supervision: receiving and logging investigational product shipments, preparing doses against protocol orders, maintaining drug accountability logs, and preparing documentation for sponsor monitoring visits.

Does every clinical trial site need a dedicated research pharmacy?

No. Low-volume sites often designate an existing pharmacist for research duties rather than building a dedicated unit. A dedicated IDS with its own space and staff generally becomes necessary once a site runs a high enough volume of drug trials, particularly ones involving sterile compounding, hazardous agents, or complex blinding, that ad hoc coverage stops being practical.